Northwest Biotherapeutics Inc: Form 10-K/A for the period ended Dec 31, 2021
Filed with the SEC on May 2, 2022 and accepted by EDGAR at May 2, 2022, 17:03 ET.
Sections
No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001104659-22-054757. Last ingested by Listed: Oct 30, 2026, 16:18 ET. Listed shows no prices and gives no investment advice.